All section Close
Tamil Nadu: COVID-19 Vaccine Beneficiaries Can Now Choose Between Covishield, Covaxin
Tamil Nadu, 19 Feb 2021 1:33 PM GMT
Editor : Shubhendu Deshmukh |
Shubhendu, the quint essential news junky, the man who loves science and politics in equal measure and offers the complete contrast to it by being a fan of urdu poetry as well.
Creatives : Abhishek M
" An engineer by profession, Abhishek is the creative producer of the team, graphic designing is his passion and travelling his get away. In more ways than one, he makes the content visually appealing."
For the first time since the immunisation drive began, the COVID-19 vaccine receivers in Tamil Nadu will have the option to choose between Covaxin and Covishield. The state is the first one to do so in India.
For the first time since the immunisation drive began, the COVID-19 vaccine receivers in Tamil Nadu will have the option to choose between Covaxin and Covishield. The state is the first one to do so in India.
"Both the vaccines have been approved by the government, and they are in stock, the state government has decided to leave it to the beneficiaries to choose between the two vaccines. The decision was taken after requests for Covaxin has come from districts that earlier did not offer it. Some people favoured Covaxin over Covishield, and they had to travel far to take the jab at one of the six districts," Principal Secretary to the Department of Health and Family Welfare, Dr J Radhakrishnan, told The New Indian Express.
At the beginning of the vaccination drive in Tamil Nadu, Director of Public Health Dr T S Selvavinayagam had said, "Beneficiaries cannot choose between Covaxin and Covishield. They can only get what is available at the time of the vaccination drive in the site."
On January 16, when the drive started, Covishield was administered at 160 vaccination sites, while Covaxin was available at only six vaccination sites.
According to data released by the Directorate of Public Health and Preventive Medicine, Covaxin was limited to six government medical colleges till February 15. But since the demand for Covaxin was rising over Covishield, the government is making the Covaxin available at more sites.
On January 13, the state had received its first batch of 20,000 doses of Covaxin, developed by Bharat Biotech and 5,36,500 doses of Covishield, developed jointly by Oxford University and AstraZeneca on January 12. As of Wednesday, February 17, Covaxin is available at 22 sites.
Also Read: As New COVID Strains Surface In India, Govt Issues Fresh Guidelines For International Travellers
Must Reads
We are an independent and public-spirited digital media platform for Indian millennials. We report news and issues that matter as well as give you the opportunity to take action.
